Mesenchymal Cell News 10.37 September 18, 2018 | |
| |
TOP STORYScientists demonstrated that an intratumoral injection of polymer-double-transfected MSCs along with prodrug ganciclovir injections could induce a significant synergistic therapeutic response both in vitro and in vivo compared to single plasmid transfections or untransfected MSCs. [Acta Biomater] Abstract | Graphical Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)IN VITROInvestigators characterized equine umbilical cord blood-MSCs and umbilical cord matrix-MSCs and investigated with particular attention their chondrogenesis potential in 3D culture with BMP-2 + TGF-ß1 in normoxia or hypoxia. [Sci Rep] Full Article Embedded MSCs showed significantly better viability in vitro after injection through a 30G needle when the gels were in the pre-gelled versus post-gelled state. [Sci Rep] Full Article The authors exposed three subtypes of human MSCs in vitro to a single, high-energy shock wave and observed increased transcription in the osteogenic master regulators, Runx2 and Dlx5, and significantly accelerated cell mineralisation. [Bone] Full Article Proteomic Profiling of Native Unpassaged and Culture‐Expanded Mesenchymal Stromal Cells (MSCs) Researchers provided for the first time a detailed characterization of native unpassaged bone marrow MSCs as well as the changes that occur during the initial expansion. Adipogenic and osteogenic differentiative potential was determined though the serial passages and correlated with immunophenotypic changes and senescence. [Cytometry A] Abstract Investigators evaluated the dental pulp stem cells’ proliferation and osteogenic differentiation in different layer-by-layer-modified gelatin sponge scaffolds including the gelatin sponge+ poly-l-lysine modification, gelatin sponge + mineralization modification, and gelatin sponge + mineralization modification + poly-l-lysine modification groups in vitro and assessed them in vivo. [J Biomater Appl] Abstract IN VIVOThe authors designed a cardiac patch to improve the retention of engrafted stem cells and provided mechanical scaffold for preventing ventricular remodeling post-myocardial infarction. [Acta Biomater] Abstract | Graphical Abstract Scientists hypothesized that pulsed focused ultrasound up‐regulates renal interferon‐γ and stimulates MSC to produce interleukin‐10 after migrating to kidneys. [J Cell Mol Med] Full Article After four days, lipopolysaccharide (LPS)‐preconditioned MSC transplantation modulated the immune response and reduced inflammation in septic mice. [J Cell Physiol] Abstract MSC-seeded ACgels promoted the closure, re-epithelialization, granulation tissue formation, and vascularization of burn wounds. ACgels alone could also promote vascularization but less effectively compared to MSC-seeded ACgels [Stem Cells Dev] Abstract Subscribe to one of our other 19 science newsletters such as ESC & iPSC News & Cell Therapy News. | |
| |
REVIEWSDesigning Stem Cell Niches for Differentiation and Self-Renewal Biomaterial strategies are being developed that aim to recapitulate stem cell niches, by engineering microenvironments with physiological-like niche properties that aim to elucidate stem cell-regulatory mechanisms, and to harness their regenerative capacity in vitro. In the future, engineered niches will prove important tools for both regenerative medicine and therapeutic discoveries. [J R Soc Interface] Full Article Visit our reviews page to see a complete list of reviews in the mesenchymal cell research field. | |
| |
INDUSTRY NEWSBone Therapeutics Announces Final Results from Phase I/IIa Allob Delayed-Union Fracture Study Bone Therapeutics announced positive final results in the Phase I/IIA delayed-union study of its allogeneic bone cell therapy product ALLOB in 21 patients, supporting the future clinical development of the delayed union indication. [Bone Therapeutics S.A.] Press Release Cellectar Biosciences, Inc. announced that the FDA has granted Rare Pediatric Disease Designation to CLR 131 for the treatment of osteosarcoma. [Cellectar Biosciences, Inc.] Press Release BrainStorm Granted New U.S. Patent for Industrial Scale Manufacturing of NurOwn® BrainStorm Cell Therapeutics Inc. announced that the United States Patent Office has granted a new US patent titled ‘METHODS OF GENERATING MESENCHYMAL STEM CELLS WHICH SECRETE NEUROTROPHIC FACTORS’. [BrainStorm Cell Therapeutics Inc.] Press Release BioCardia®, Inc. announced the issuance of two United States patents. U.S. Patent No. 10,035,982 relates to methods of preparing culture-expanded cells for the treatment of heart failure. As the second issued patent, U.S Patent No. 10,071,226 describes a system for delivery of biotherapeutic agents to the heart. [BioCardia®, Inc.] Press Release | |
| |
POLICY NEWSThe governing council of AAAS (publisher of Science) in Washington, D.C., unanimously adopted a policy on sexual harassment and other misconduct by scientists who have been elected as AAAS fellows. Starting on 15 October, fellows who have been proved to have violated professional ethics—which are defined as including sexual harassment—may be stripped of the prestigious honor. [ScienceInsider] Editorial Mass Resignation Guts Board of Prestigious Cochrane Collaboration The board of the Cochrane Collaboration, a prestigious group that reviews health evidence, has been reduced from 13 to 6 members, following a controversial vote to expel a member for the first time in its 25-year existence. [Nature News] Editorial NIH Gets $2 Billion Boost in Final 2019 Spending Bill Congress has approved a $2 billion raise, to $39.1 billion, for the National Institutes of Health (NIH) in a 2019 spending bill approved by House of Representatives and Senate negotiators. [ScienceInsider] Editorial
| |
EVENTSNEW Gordon Research Conference: Cartilage Development and Regeneration and Their Implications in Disease Therapies Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Tenure Track Assistant Professor – Regenerative Biology (Massachusetts General Hospital) Assistant Professor – Stem Cell and Regenerative Biology (Columbia University) Postdoctoral Researcher – Interdisciplinary (Oregon Health & Science University) Faculty Positions – Biomedical Research (Memorial Sloan Kettering Cancer Center) Postdoctoral Research Fellow – Spinal Fusion (Hopkins Spinal Fusion Laboratory) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|